|
|
- 2017
重视阿尔茨海默病和老年痴呆症的人群干预研究
|
Abstract:
| [1] | Organization WH. Dementia: a public health priority here[J]. Perspect Public Health, 2012, 5(3): 123-125. |
| [2] | Bennett DA, Schneider JA, Tang Y, et al. The effect of social networks on the relation between Alzheimers disease pathology and level of cognitive function in old people: a longitudinal cohort study[J]. Lancet Neurol, 2006, 5(5): 406-412. |
| [3] | Yang G, Wang Y, Zeng Y, et al. Rapid health transition in China, 1990-2010: findings from the global burden of disease study 2010[J]. Lancet, 2013, 381(9882): 1987-2015. |
| [4] | Morbelli S, Nobili F. Cognitive reserve and clinical expression of Alzheimers disease: evidence and implications for brain PET imaging[J]. Am J Nucl Med Mol Imaging, 2014, 4(3): 239-247. |
| [5] | Norton S, Matthews FE, Barnes DE, et al. Potential for primary prevention of Alzheimers disease: an analysis of population-based data[J]. Lancet Neurol, 2014, 13(8): 788-794. |
| [6] | Jia J, Wang F, Wei C, et al. The prevalence of dementia in urban and rural areas of China[J]. Alzheimers Dement, 2014, 10(1): 1-9. |
| [7] | Alzheimers Disease International(ADI). World Alzheimer Report 2015, the global impact of dementia: an analysis of prevalence, incidence, cost and trends[EB/OL].(2015-08)[2017-04-08]. http: //www.alz.co.uk/research/world-report-2015. |
| [8] | Chan KY, Wang W, Wu JJ, et al. Epidemiology of Alzheimers disease and other forms of dementia in China, 1990-2010: a systematic review and analysis[J]. Lancet, 2013, 381(9882): 2016-2023. |
| [9] | Xu J, Wang J, Wimo A, et al. The economic burden of dementia in China, 1990-2030: implications for health policy[J]. Bull World Health Organ, 2017, 95(1): 18-26. |
| [10] | 仇成轩. 社会心理因素、遗传易感性及其交互影响在认知老化过程中的作用[J]. 中华行为医学与脑科学杂志, 2012, 21(4): 295-298. QIU Chengxuan. Psychosocial factors, genetic susceptibility and their interaction in cognitive aging[J]. Chin J Behav Med Brain Sci, 2012, 21(4): 295-298. |
| [11] | Stern Y. Cognitive reserve in ageing and Alzheimers disease[J]. Lancet Neurol, 2012, 11(11): 1006-1012. |
| [12] | Langa KM, Larson EB, Crimmins EM, et al. A comparison of the prevalence of dementia in the United States in 2000 and 2012[J]. JAMA Intern Med, 2017, 177(1): 51-58. |
| [13] | Matthews FE, Stephan BC, Robinson L, et al. A two decade dementia incidence comparison from the cognitive function and ageing studies I and II[J]. Nat Commun, 2016,7: 11398. doi: 10.1038/ncomms11398. |
| [14] | Solomon A, Mangialasche F, Richard E, et al. Advances in the prevention of Alzheimers disease and dementia[J]. J Intern Med, 2014, 275(3): 229-250. |
| [15] | Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people(FINGER): a randomized controlled trial[J]. Lancet, 2015, 385(9984): 2255-2263. |
| [16] | Brookmeyer R, Gray S, Kawas C. Projections of Alzheimers disease in the United States and the public health impact of delaying disease onset[J]. Am J Public Health, 1998, 88(9): 1337-1342. |
| [17] | 杜怡峰. 应加强我国阿尔茨海默病的早期防治研究[J].中华神经科杂志, 2016, 49(9): 667-672. DU Yifeng. Researches on early intervention of Alzheimers disease should be strengthened[J]. Chin J Neurol, 2016, 49(9): 667-672. |
| [18] | Qiu C, Kivipelto M, von Strauss E. Epidemiology of Alzheimers disease: occurrence, determinants, and strategies toward intervention[J]. Dialogues Clin Neurosci, 2009, 11(2): 111-128. |
| [19] | Winblad B, Amouyel P, Andrieu S, et al. Defeating Alzheimers disease and other dementias: a priority for European science and society[J]. Lancet Neurol, 2016, 15(5): 455-532. |
| [20] | Viswanathan A, Rocca WA, Tzourio C. Vascular risk factors and dementia: how to move forward?[J]. Neurology, 2009, 72(4): 368-374. |
| [21] | Loy CT, Schofield PR, Turner AM, et al. Genetics of dementia[J]. Lancet, 2014, 383(9919): 828-840. |
| [22] | Qiu C, Fratiglioni L. A major role for cardiovascular burden in age-related cognitive decline[J]. Nat Rev Cardiol, 2015, 12(5): 267-277. |
| [23] | 李娅, 龙慧, 楚兰, 等. 阿尔茨海默病与血管性危险因素关系研究: 中国学者海外报道[J]. 中国现代神经疾病杂志,2015, 15(7): 518-523. LI Ya, LONG Hui, CHU Lan, et al. Studies on the association between Alzheimers disease and vascular risk factors: reports from China[J]. Chin J Contemp Neurol Neurosurg, 2015, 15(7): 518-523. |
| [24] | Xu W, Tan L, Wang HF, et al. Meta-analysis of modifiable risk factors for Alzheimers disease[J]. J Neurol Neurosurg Psychiatry, 2015, 86(12): 1299-1306. |
| [25] | Wu YT, Fratiglioni L, Matthews FE, et al. Dementia in Western Europe: epidemiological evidence and implications for policy making[J]. Lancet Neurol, 2016, 15(1): 116-124. |
| [26] | Moll van Charante EP, Richard E, Eurelings LS, et al. Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia(preDIVA): a cluster-randomised controlled trial[J]. Lancet, 2016, 388(10046): 797-805. |
| [27] | Qiu C. Preventing Alzheimers disease by targeting vascular risk factors: hope and gap[J]. J Alzheimers Dis, 2012, 32(3): 721-731. |
| [28] | Qiu C, Xu W, Fratiglioni L. Vascular and psychosocial factors in Alzheimers disease: epidemiological evidence toward intervention[J]. J Alzheimers Dis, 2010, 20(3): 689-697. |
| [29] | Qiu C, Sigurdsson S, Zhang Q, et al. Diabetes, markers of brain pathology and cognitive function: the age, gene/environment susceptibility-reykjavik study[J]. Ann Neurol, 2014, 75(1): 138-146. |
| [30] | 何燕,余林,闫志民,等. 认知储备的测量及其在认知老化中的应用[J].心理科学进展, 2015, 23(3): 430-438. HE Yan, YU Lin, YAN Zhimin, et al. Quantification of cognitive reserve and application research in cognitive aging[J]. Adv Psychol Sci, 2015, 23(3): 430-438. |
| [31] | Brayne C, Ince PG, Keage HA, et al. Education, the brain and dementia: neuroprotection or compensation?[J]. Brain, 2010, 133(Pt 8): 2210-2216. |
| [32] | Brodaty H, Breteler MM, Dekosky ST, et al. The world of dementia beyond 2020[J]. J Am Geriatr Soc, 2011, 59(5): 923-927. |
